SAGE Therapeutics (SAGE) to Offer $300M in Common Stock
November 13, 2017 4:01 PM
Sage Therapeutics (NASDAQ: SAGE), a clinical-stage biopharmaceutical company developing novel medicines to treat life-altering central nervous system (CNS) disorders, today ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
